Robert N. Klein II, Fresno, CA
$3,120,617 to winners, $1,000 to losers
Robert N. Klein II is an attorney and advocate of stem cell research. He was a chief author of Proposition 71, the 2004 ballot measure that allowed the state to sell bonds to pay for up to $3 billion in stem cell research. It passed. Klein, who spent more than $3 million supporting the proposition, has said his younger son’s diagnosis of juvenile diabetes in 2001 prompted his support of medical research. Klein was the first chairman of the Governing Board of the California Institute for Regenerative Medicine, which oversees the funding directed from Prop. 71. He served in that role for more than six years before stepping down in June and becoming chairman emeritus. He is president of Klein Financial Corp., a real estate investment consulting company. Klein has bachelor’s and law degrees from Stanford University.
Total contributions: $3,144,964
List of contributions
Source: Contribution data from National Institute on Money in State Politics
Credits: Interactive by Michael Corey, Coulter Jones and Chase Davis. Reporting by Coulter Jones. Badge design by Thomas Guffey. Additional reporting by Stanford University students enrolled in a Communications Department investigative reporting class under the direction of California Watch Editorial Director Mark Katches. The project began in January 2011. Students participating were: Devin Banerjee, Daniel Bohm, Kathleen Chaykowski, Tom Corrigan, Cassandra Feliciano, Jamie Hansen, Amy Harris, Josh Hicks, Ellen Huet, Julia James, Paul Jones, Ryan Mac, Valentina Nesci, Dean Schaffer, Elizabeth Titus and Kareem Yasin. Bohm, Hansen, Huet, Harris and Titus continued to work on the project as California Watch interns under the direction of Associate Editor Denise Zapata.